Cognitive impairment in people living with HIV: consensus recommendations for a new approach-Reference-Cited by-同舟云学术

Cognitive impairment in people living with HIV: consensus recommendations for a new approach

Published:2023-06-13 Issue:7 Volume:19 Page:424-433
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Nightingale Sam^ORCID,Ances Beau,Cinque Paola,Dravid Ameet,Dreyer Anna J.^ORCID,Gisslén Magnus,Joska John A.,Kwasa Judith,Meyer Ana-Claire,Mpongo Nombeko,Nakasujja Noeline,Pebody Roger,Pozniak Anton,Price Richard W.^ORCID,Sandford Christopher,Saylor Deanna,Thomas Kevin G. F.,Underwood Jonathan^ORCID,Vera Jaime H.,Winston Alan

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

https://www.nature.com/articles/s41582-023-00813-2.pdf

Reference105 articles.

1. Antinori, A. et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 1789–1799 (2007).

2. Wang, Y. et al. Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis. Neurology 95, e2610–e2621 (2020).

3. Frescura, L. et al. Achieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS ONE 17, e0272405 (2022).

4. van Sighem, A. I. et al. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS 24, 1527–1535 (2010).

5. Torti, C., Foca, E., Cesana, B. M. & Lescure, F. X. Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? BMC Med. 9, 138 (2011).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the lived experience research priorities for improving health-related quality of life in people living with HIV with cognitive impairment;HIV RES CLIN PRACT;2024

2. Brain plasticity and adolescent HIV: A randomised controlled trial protocol investigating behavioural and hemodynamic responses in attention cognitive rehabilitation therapy;MethodsX;2024-12

3. Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

4. Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort study;The Lancet HIV;2024-09

5. Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse;Cells;2024-08-24